MB-107 Granted Rare Pediatric Disease Designation for X-Linked Severe Combined Immunodeficiency
This past week, biopharmaceutical company Mustang Bio announced that their gene therapy candidate MB-107 received Rare Pediatric Disease Designation. The gene therapy candidate is designed to treat X-linked severe…